| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |